Track 1: Neuroscience and Neuro-Oncology

Neuroscientists are interested in the brain's impact on behaviour and intellectual abilities. Neuroscience is concerned not only with the normal functioning of the sensory system, but also with what happens to the sensory system when people have neurological, mental, or neurodevelopmental problems.

The European Society for Medical Oncology's "Basics for Clinicians" framework relies heavily on neuro-oncology. Despite the fact that vital cerebrum tumours are uncommon and rarely encountered outside of specific oncology departments, basic knowledge of the arrangement and board recommendations for gliomas is crucial to ensure adequate patient attention in each therapeutic context.

Track 2: Molecular Neuro-Oncology and Genomics

Molecular neuro-oncology has recently begun to explain the evolving nature of brain tumours and to define oncogenic pathways that may be amenable to targeted treatment. Brain tumours frequently upregulate development factor flagging pathways, which may contribute to oncogenesis via autocrine and paracrine mechanisms.

Genomics is the study of a living organism's entire genome, which includes components from inherited characteristics. Genomics arranges, gathers, and breaks down the design and capacity of genomes using a combination of recombinant DNA, DNA sequencing tools, and bioinformatics. It differs from 'conventional hereditary attributes' in that it considers a life form's entire supply of intrinsic material rather than individual qualities or quality items.

Track 3: Pediatrics and Geriatrics Neuro-Oncology

Track 4: Neural Stem Cells and Neuroimmunology (NSCs)

Juvenile organisms are undifferentiated organisms "Unspecialized cell that has the ability to transform into a specific type of cell when it is young. These cells have the appearance of a clear sheet of paper "cellular units They resemble clear cells that may transform into numerous types of particular cells, much like a clear piece of paper. Immature microorganisms can continue to isolate as long as they are alive (this is referred to as "self-re-establishing"), and they have two notable features: they can produce new undifferentiated organisms and they can transform into various types of more particular cells. There are neural undifferentiated cells in the cerebrum.

Track 5: Cancer and Brain Tumors

A brain tumour is a mass or growth of abnormal cells in the brain.

There are many different types of brain tumours. Some brain tumours are benign (pleasant), while others are malignant (hazardous) (threatening). Tumors in the cerebrum might begin in the mind (essential cerebrum tumours), or malignant growth can begin in other parts of your body and spread to your cerebrum (auxiliary, or metastatic, mind tumors).

The rate at which a brain tumour grows might vary dramatically. The rate of growth, like the size of a brain tumour, determines what your sensory system's capacity will be.The type of cerebrum tumour you have, as well as its size and location, influence your treatment options.

Track 6: Pregnancy and Neuro-Oncology

Chemotherapy is the use of toxic medicines to kill a cancerous development in your body. Chemotherapy and other anticancer drugs might harm the hatchling, induce birth abnormalities, and result in preterm delivery, especially if used during the first trimester of pregnancy. During the second and third trimesters, a few chemotherapies and other cancer-fighting drugs are safe to use.

Track 7: Neuro-Oncology and Vision Science

Chemotherapy is the use of toxic medicines to kill a cancerous development in your body. Chemotherapy and other anticancer drugs might harm the hatchling, induce birth abnormalities, and result in preterm delivery, especially if used during the first trimester of pregnancy. During the second and third trimesters, a few chemotherapies and other cancer-fighting drugs are safe to use.

Track 8: Neurostimulation, Glutamate Neurotransmission and Neuroimaging in Cognitive Neuroscience

Neurostimulation relieves pain by disrupting the anguish signals that travel between the spinal cord and the brain. Overall, it outmanoeuvres your misery.

Glutamate is a prominent synapse found in more than 90% of all neural connections in the cerebrum and is a naturally occurring particle used by nerve cells to communicate with other cells in the focused sensory system.

Track 9: Biomarkers in Neuro-Oncology

Biomarkers are used to educate doctors on how to treat brain tumours. One application is to properly group tumours with similar hereditary/genomic characteristics and to arrange preparations separately for each gathering. The biomarker is used to predict patient reaction so that the optimum treatment for patients can be chosen based on their tumour characteristics. Given the relatively small numbers of individuals available for preliminaries, preliminary plans that pick unselected participants are insufficient for identifying treatments that are successful only in subsets of patients.

Track 10: Neuropathology and Neuroradiology

Neuroradiology is a branch of radiology that focuses on using neuroimaging techniques to analyse and depict anomalies of the focal and fringe sensory systems, spine, and head and neck.

Track 11: Psycho-Oncology and Psychosocial Advances

The psycho-role, oncologist's as played by the dying, extends beyond the treatment of mental symptoms and disorders to areas such as existential difficulties, family and guardian support, deprivation, expert patient correspondence, schooling, and preparation.

Track 12: Surgical Neurology and Neuro-Oncology

It is the therapeutic specialty concerned with locating and treating patients with injuries to, or illnesses/problems of, the brain, spinal cord and spinal segment, and fringe nerves throughout the body. Both adult and paediatric patients are included in neurosurgical care's claim to fame. A neurological specialist may give careful or maybe non-careful consideration depending on the idea of the damage or sickness.

Track 13: Neuro-Oncology Cognition Measurement and Treatment

Track 14: Genetic medicine:Is This The Future Treatment of Neuro-Oncology?